GlassScriptPhysician profile
Paul M Steinwald
NPI 1467488221
$6,391.45
in general payments reported to CMS, 2019-2025
17 companies · $1,754 in 2025
The $1,754 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $270 · 2021: $1,068 · 2022: $574 · 2023: $824 · 2024: $1,230 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,807.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,024.28 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $1,003.82 | 2019-2022 | |
| Allergan, INC. | $640.17 | 2019-2022 | |
| Integra Lifesciences Corporation | $588.02 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Abbvie INC. | $586.55 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Davol INC. | $540.51 | 2022-2025 | Phasix Mesh |
| Motiva USA, LLC | $433.94 | 2024-2025 | |
| Mentor Worldwide LLC | $309.01 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Bard Peripheral Vascular, INC. | $246.30 | 2021 | |
| Innovation Technologies INC | $195.79 | 2022-2025 | Irrisept |
| Becton, Dickinson and Company | $192.19 | 2025 | Phasix Mesh |
| Galderma Laboratories, L.P. | $172.83 | 2019-2021 | |
| Apyx Medical Corporation | $156.88 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $133.76 | 2024 | |
| Merck Sharp & Dohme LLC | $122.48 | 2021-2025 | Bridion |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $24.37 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Steinwald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.